Daiichi Sankyo is seeking innovative, robust bioassay systems that accurately model neuronal dysfunction in neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS).

Up to $150,000 USD in funding is available for a 12-month project with potential follow-on funding for 1 year. The deadline to apply for this partnership opportunity is January 31st. You can read more about the project call here.